Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Scharla

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
MMW Fortschritte Der Medizin|March 22, 2000
[Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis]S H Scharla
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Treatment of tumor hypercalcemia with clodronateR Ziegler, S H Scharla
Klinische Wochenschrift|January 4, 1991
[Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)]S H Scharla, A Grauer, R Ziegler
Zeitschrift Fur Rheumatologie|April 19, 2000
[Inflammation mediated osteopenia (IMO): therapeutic effect of D-hormone and the role of cytokines]S H Scharla, U G Lempert, I Kamilli
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 28, 1999
Prevalence of low bone mass and endocrine disorders in hip fracture patients in Southern GermanyS H Scharla, S Wolf, R Düll, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 15, 1996
[Bisphosphonate therapy of Paget's disease of bone with pamidronate]A Grauer, B Klar, J Knaus, et al.
Bone and Mineral|May 1, 1991
Influence of parathyroidectomy, 1,25-dihydroxyvitamin D3 and high dietary calcium intake on demineralized bone matrix powder-induced bone formation in the ratU G Lempert, S H Scharla, H W Minne, et al.
European Journal of Endocrinology|September 1, 1994
Effect of tumor necrosis factor-alpha on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblastsS H Scharla, D D Strong, S Mohan, et al.
Endocrinology|December 1, 1991
1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblastsS H Scharla, D D Strong, S Mohan, et al.
Human Reproduction (Oxford, England)|May 1, 1989
Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyomaS Waibel-Treber, H W Minne, S H Scharla, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
MMW Fortschritte Der Medizin|March 22, 2000
[Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis]S H Scharla
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Treatment of tumor hypercalcemia with clodronateR Ziegler, S H Scharla
Klinische Wochenschrift|January 4, 1991
[Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)]S H Scharla, A Grauer, R Ziegler
Zeitschrift Fur Rheumatologie|April 19, 2000
[Inflammation mediated osteopenia (IMO): therapeutic effect of D-hormone and the role of cytokines]S H Scharla, U G Lempert, I Kamilli
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 28, 1999
Prevalence of low bone mass and endocrine disorders in hip fracture patients in Southern GermanyS H Scharla, S Wolf, R Düll, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 15, 1996
[Bisphosphonate therapy of Paget's disease of bone with pamidronate]A Grauer, B Klar, J Knaus, et al.
Bone and Mineral|May 1, 1991
Influence of parathyroidectomy, 1,25-dihydroxyvitamin D3 and high dietary calcium intake on demineralized bone matrix powder-induced bone formation in the ratU G Lempert, S H Scharla, H W Minne, et al.
European Journal of Endocrinology|September 1, 1994
Effect of tumor necrosis factor-alpha on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblastsS H Scharla, D D Strong, S Mohan, et al.
Endocrinology|December 1, 1991
1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblastsS H Scharla, D D Strong, S Mohan, et al.
Human Reproduction (Oxford, England)|May 1, 1989
Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyomaS Waibel-Treber, H W Minne, S H Scharla, et al.
Pageof 3